Drug Importation and the Deadly Challenge of Screening 275 Million Packages a Year

The Food and Drug Administration (FDA) in their report U.S. Food and Drug Administration and the International Mail Facilities (IMFs), describes the daunting job that Customs and Border Protection (CBP) faces when attempting to weed out counterfeit medications and packages containing illicit fentanyl. In 2017, IMFs received 275 million packages. Of these, 10,000 were screened by CBP, and of those 86% contained drugs. The investigation of a suspect package is incredibly time-consuming; an experienced FDA investigator might take as long as 20 minutes to process a package containing just on product.

[...]

Partnership For Safe Medicines Urges Passage of the STOP Act to Increase Inspections for Dangerous Synthetic Opioids

Partnership For Safe Medicines Urges Passage of the STOP Act to Increase Inspections for Dangerous Synthetic Opioids Legislation will increase surveillance of primary smuggling route for fentanyl WASHINGTON (May 24, 2018) – The Partnership for Safe Medicines (PSM) today urged passage of the Synthetics Trafficking and Overdose Prevention Act of 2017 (S.372), also known as…

[...]

PSM Board President Dr. Marv Shepherd Explains the Dangers of Drug Importation

Dr. Shepherd was interviewed on a local Austin radio station and described for listeners the realities of the counterfeit medication economy, and the dangers U.S. citizens face from imported medication. After William Scully, owner of the unlicensed pharmaceutical importer Medical Device King/Pharmalogical, was convicted on charges relating to his drug importation business, Bill Swail, host…

[...]

Leading Patient Advocacy Group Applauds Conviction of Illegal Drug Supply Operators

The Partnership for Safe Medicines released the following statement regarding the verdict of William Scully for operating an illegitimate drug supply company called Pharmalogical Inc., which conducts business as Medical Device King. The defendant sold more than $14 million worth of illegal products including misbranded cancer medicine, unapproved birth control devices, and other medical products…

[...]